The incidence of kidney transplant from hepatitis C virus infected (HCV+) donors to HCV negative (HCV-) recipients is rising due to the availability of highly effective direct-acting antiviral agents (DAA)… Click to show full abstract
The incidence of kidney transplant from hepatitis C virus infected (HCV+) donors to HCV negative (HCV-) recipients is rising due to the availability of highly effective direct-acting antiviral agents (DAA) with high cure rates above 95%.(1, 2) Kidney transplants from HCV infected donors have similar outcomes then non infected organs hence use of these organs should be optimized to minimize the current organ shortage.
               
Click one of the above tabs to view related content.